Thanacoody, R H K

Factors affecting drug concentrations and QT interval during thioridazine therapy. [electronic resource] - Clinical pharmacology and therapeutics Nov 2007 - 555-65 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1532-6535

10.1038/sj.clpt.6100195 doi


Adult
Age Factors
Aged
Aged, 80 and over
Alleles
Antipsychotic Agents--administration & dosage
Aryl Hydrocarbon Hydroxylases--genetics
Cross-Sectional Studies
Cytochrome P-450 CYP2C19
Cytochrome P-450 CYP2D6--genetics
Dopamine Antagonists--adverse effects
Female
Genetic Variation
Genotype
Heart Conduction System--drug effects
Humans
Linear Models
Long QT Syndrome--blood
Male
Mesoridazine--adverse effects
Middle Aged
Mixed Function Oxygenases--genetics
Risk Factors
Schizophrenia--drug therapy
Sex Factors
Smoking--adverse effects
Thioridazine--administration & dosage
White People--genetics